Moneycontrol
HomeNewsBusinessExplained | The $1 billion Qatar Airways-Airbus dispute and how it may affect India
Trending Topics

Explained | The $1 billion Qatar Airways-Airbus dispute and how it may affect India

Indian airlines may not be directly or immediately affected by the dispute. However, if Airbus loses the case against Qatar Airways, it could mar the aircraft maker’s prospects in India.

April 06, 2022 / 19:23 IST
Story continues below Advertisement

Airbus A350 XWB (Image Source: Airbus)

Early this week, Airbus revoked a contract to deliver an A350 aircraft to Qatar Airways, the third such cancellation by the manufacturer. The West Asian airline rejected delivery of the aircraft in a continuing dispute over flaws on the aircraft surface that it says compromises lightning protection. Airbus denied there were any safety issues.

Qatar Airways has grounded 23 A350 aircraft and is seeking about $1 billion as compensation. The dispute is currently before a UK court.

Story continues below Advertisement

What is the dispute between Qatar Airways and Airbus?

The dispute between Qatar Airways and Airbus pertains to claims by the airline that layers of paint on Airbus’s widebody A350 jets have been damaged, putting the aircraft’s lightning protection system and fuel tanks at risk.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show